SERUM-ALBUMIN - ITS RELATIONSHIP TO MARROW AND RENAL TOXICITY FROM PLATINUM-BASED COMBINATION CHEMOTHERAPY

被引：6

作者：

BELINSON, JL ^{[1
]}

JARRELL, MA ^{[1
]}

MCCLURE, M ^{[1
]}

KULIG, PM ^{[1
]}

BADGER, GJ ^{[1
]}

机构：

[1] UNIV VERMONT,DEPT BIOMETRY,BURLINGTON,VT 05401

来源：

GYNECOLOGIC ONCOLOGY | 1990年 / 37卷 / 01期

关键词：

D O I：

10.1016/0090-8258(90)90315-C

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

One hundred and three patients treated with CAP chemotherapy were evaluated to determine the relationship between low prechemotherapy serum albumin (<3 g/dl) and low WBC nadir (<2000 cells/mm3). Additionally, the relationship of serum albumin to renal toxicity (Δ serum creatinine) was examined. Low prechemotherapy serum albumin appears to be a marker for advanced disease, but does not appear to predict marrow or renal toxicity. © 1990.

引用

页码：93 / 95

页数：3

共 12 条

[1]

BAGLEY CM, 1973, CANCER RES, V33, P226

[2]

BANNISTER SJ, 1977, CLIN CHEM, V23, P2258

[3]

BELINSON JL, 1984, CANCER, V54, P1983, DOI 10.1002/1097-0142(19841101)54:9<1983::AID-CNCR2820540933>3.0.CO

[4]

2-2

[5]

BELINSON JL, IN PRESS MANAGEMENT

[6]

DECONTI RC, 1973, CANCER RES, V33, P1310

[7] CLINICAL PHARMACOKINETICS OF CYCLOPHOSPHAMIDE [J].

GROCHOW, LB ;

COLVIN, M .

CLINICAL PHARMACOKINETICS, 1979, 4 (05) :380-394

[8] LIQUID-CHROMATOGRAPHIC ANALYSIS OF ADRIAMYCIN AND METABOLITES IN BIOLOGICAL-FLUIDS [J].

ISRAEL, M ;

PEGG, WJ ;

WILKINSON, PM ;

GARNICK, MB .

JOURNAL OF LIQUID CHROMATOGRAPHY, 1978, 1 (06) :795-809

[9]

MCDEVITT DG, 1976, CLIN PHARMACOL THER, V20, P152

[10]

SHOEMAN DW, 1975, J PHARMACOL EXP THER, V195, P84

← 1 2 →